Pulse Biosciences, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Pulse Biosciences, Inc. (PLSE) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $15.28 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-19
- Pulse Biosciences, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $15.28M, a 35.82% increase from fiscal 2024.
- Pulse Biosciences, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $11.25M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $15.28M 10-K · filed 2026-02-19 |
| 2024-12-31 | $11.25M 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |